JB Chemicals & Pharmaceuticals Ltd.
Snapshot View

View in App

Prices View details >>

1942.60 -19.20 ▼-1.0%

29 March 2023, 04:01:00 PM
Volume: 1,584

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.jbpharma.com
Market Cap 15,111.84 Cr.
Enterprise Value(EV) 15,371.21 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 52.61 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 36.93 Trailing Twelve Months Ending 2022-12
Industry PE 32.17 Trailing Twelve Months Ending 2022-12
Book Value / Share 312.94 Trailing Twelve Months Ending 2022-12
Price to Book Value 6.21 Calculated using Price: 1,942.60
Dividend Yield 0.84 Period Ending 2022-03
No. of Shares Subscribed 7.74 Cr. 77,377,584 Shares
FaceValue 2
Company Profile
J. B. Chemicals & Pharmaceuticals is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and APIs. JBCPL is widely committed to manufacturing a range of innovative specialty products that include various pharmaceutical dosage forms like tablets, injectable (vials, ampoules, form fill seal), creams & ointments, lozenges, herbal liquids and capsules. In India and International markets, JBCPL is also known as Unique Pharmaceutical Laboratories and is a division of JBCPL.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.98%
1 Week
-0.85%
1 Month
+0.45%
3 Month
+0.48%
6 Month
+1.48%
1 Year
+24.33%
2 Year
+58.31%
5 Year
+528.27%
10 Year
+2541.20%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 5.99 9.86 14.80 14.48 9.89 13.28 18.69 27.64 19.89
Return on Capital Employed (%) 8.50 13.49 17.72 16.87 13.70 19.59 23.71 36.53 25.48
Return on Assets (%) 4.64 7.08 9.21 8.99 6.43 8.52 12.53 19.55 13.69

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 1,043 995 1,184 1,364 1,442 1,480 1,435 1,810 2,134 2,315
Non Curr. Liab. 32 33 31 27 46 65 63 72 79 327
Curr. Liab. 276 460 797 693 737 782 516 687 852 556
Minority Int. 2 2 3 3 3 4 4
Equity & Liab. 1,351 1,487 2,014 2,086 2,226 2,329 2,017 2,572 3,069 3,198
Non Curr. Assets 370 586 832 879 718 741 741 679 1,326 1,658
Curr. Assets 981 901 1,182 1,207 1,509 1,589 1,276 1,894 1,743 1,541
Misc. Exp. not W/O
Total Assets 1,351 1,487 2,014 2,086 2,226 2,329 2,017 2,572 3,069 3,198

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 1,022 1,144 1,232 1,368 1,414 1,643 1,775 2,043 2,424 3,012
Other Income 38 11 57 54 55 41 51 117 40 7
Total Income 1,060 1,155 1,288 1,422 1,469 1,685 1,826 2,159 2,464 3,019
Total Expenditure -874 -964 -1,026 -1,140 -1,215 -1,337 -1,397 -1,486 -1,882 -2,355
PBIDT 186 191 263 283 254 347 428 673 583 664
Interest -6 -7 -11 -5 -3 -5 -3 -7 -5 -24
Depreciation -28 -39 -41 -47 -57 -56 -66 -69 -73 -105
Taxation -26 -45 -50 -46 -55 -93 -77 -148 -119 -129
Exceptional Items -65 -10
PAT 62 100 161 184 139 194 272 449 386 407
Minority Interest 0 0 0 -1 0 -1 -1 0
Share Associate 1
Other Related Items
Consolidated Net Profit 62 100 163 184 138 193 272 448 385 407
Adjusted EPS 7 12 19 22 17 24 35 58 50 53

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 84 -14 127 140 201 123 194 276 315 170
Cash Fr. Inv. -116 -143 -112 -28 -45 -21 -28 24 -231 2
Cash Fr. Finan. -31 12 -1 -100 -184 -60 -156 -306 -87 -138
Net Change -63 -144 13 13 -28 43 11 -6 -3 34
Cash & Cash Eqvt 156 12 25 9 -21 21 32 26 22 57

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 55.91 55.91 55.91 55.91 54.00 54.00 54.00 53.96 53.95
Public 44.09 44.09 44.09 44.09 46.00 46.00 46.00 46.04 46.05
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 30 Mar 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of letter of confirmation for duplicate share certificates - Intimation under regulation 39(3) the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015
Thu, 02 Mar 2023
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of Equity Shares on exercise of Stock options pursuant to Employee Stock Option Scheme
Mon, 13 Feb 2023
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Disclosure under regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 - Transcript of Investors/Analysts call

Technical Scans View Details >>

Wed, 29 Mar 2023
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 2 Years High Increase in 2 Years
High Increase in 5 Years High Increase in 5 Years
Closing Near 20 SMA Closing Near 20 SMA
Close Crossing 20 SMA From Above Close Crossing 20 SMA From Above

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 237,702.12 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. 76,011.65 4,564.50 +0.8%
Divi's Laboratories Ltd. 74,827.63 2,818.70 +0.5%
Cipla Ltd. 71,662.87 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. 62,756.97 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. 52,113.83 1,554.65 +0.7%
Zydus Lifesciences Ltd. 49,628.37 490.30 +1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 56.44 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.86 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 31.22 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 27.16 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 82.20 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 63.32 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 24.08 490.30 +1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.36 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.37 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 5.66 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 3.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 9.90 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 7.53 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.77 490.30 +1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 0.04 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 490.30 +1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 490.30 +1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 490.30 +1.2%

FAQ's On JB Chemicals & Pharmaceuticals Ltd.

What is JB Chem & Pharma share price?
Can I buy JB Chem & Pharma shares now?
What is the Dividend Yield of JB Chem & Pharma?
What is the Market Cap of JB Chem & Pharma?
What are the key metrics to analyse JB Chem & Pharma?
What is the 52 Week High and Low of JB Chem & Pharma?
What is the trend of JB Chem & Pharma share price?